Internal Medicine · San Francisco, CA
NPI
1396087342
Since 2013
Specialty
Internal Medicine
Code 207R00000X
Group practices
7
Medicare group memberships
Hospitals
5
Hospital affiliations
400 Parnassus Ave Fl 5
San Francisco, CA, 94143
Phone (415) 353-2961
Groups this clinician bills Medicare through
Medicare paid, 2024
$48K
1,003 services
Medicare patients, 2024
342
Average age 72
Drug cost, 2024
$1.6M
1,296 prescriptions
Company payments, 2025
$9,966
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Beth S Zha was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 196 times for 133 patients. In total Beth S Zha billed 1,003 services in 35 codes, and Medicare paid $48K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-04-29.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 196 | 133 | $14.03 | $2,749 |
| 99215 Office E&M - Established | Facility | 167 | 119 | $123.01 | $21K |
| 94010 Pulmonary Function Testing | Facility | 120 | 117 | $6.84 | $820 |
| 99421 Office/Outpatient Services | Facility | 109 | 61 | $11.19 | $1,220 |
| 94729 Pulmonary Function Testing | Facility | 86 | 86 | $7.62 | $655 |
| 99214 Office E&M - Established | Facility | 54 | 47 | $74.89 | $4,044 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 52 | 32 | $26.47 | $1,377 |
| 99291 Critical Care E&M | Facility | 33 | 25 | $179.10 | $5,910 |
| 99441 Telephone Services | Facility | 23 | 20 | $29.81 | $686 |
| 99442 Telephone Services | Facility | 19 | 15 | $58.72 | $1,116 |
| 99205 Office E&M - New | Facility | 19 | 19 | $145.48 | $2,764 |
| 94618 Pulmonary Function Testing | Facility | 19 | 19 | $19.44 | $369 |
| 36556 Venous Catheter Insertion | Facility | 15 | 12 | $71.19 | $1,068 |
| 94726 Pulmonary Function Testing | Facility | 15 | 15 | $10.46 | $157 |
| 94060 Pulmonary Function Testing | Facility | 13 | 13 | $8.98 | $117 |
By year: 2022 $34K for 327 services; 2023 $43K for 427 services; 2024 $48K for 1,003 services.
Medicare prescription drug claims, 2024
In 2024, the drug Beth S Zha prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 146 prescriptions and refills. In total Beth S Zha wrote 1,296 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 146 | 197 | 69 | $3,817 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 132 | 163 | 33 | $74K |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 88 | 130 | 24 | $60K |
| Azithromycin Generic | 81 | 157 | 29 | $2,079 |
| Spiriva Respimat Tiotropium Bromide | 53 | 77 | 15 | $41K |
| Montelukast Sodium Generic | 51 | 83 | 13 | $315 |
| Levalbuterol Tartrate Hfa Levalbuterol Tartrate | 49 | 61 | 19 | $3,411 |
| Ethambutol Hcl Generic | 44 | 66 | Under 11 | $2,010 |
| Colistimethate Colistin (Colistimethate Na) | 37 | 41 | Under 11 | $15K |
| Rifampin Generic | 37 | 45 | Under 11 | $2,862 |
| Incruse Ellipta Umeclidinium Bromide | 37 | 45 | 11 | $14K |
| Ceftazidime Generic | 36 | 37 | Under 11 | $3,646 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 29 | 29 | 27 | $295 |
| Levofloxacin Generic | 23 | 23 | 19 | $298 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 23 | 25 | 16 | $209 |
Brand drugs: 681 claims; generic drugs: 615 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Beth S Zha $9,966 ($9,966 in general payments such as food, travel and fees) from 3 companies. The largest payer was Insmed, Inc. with $6,799.
| Company | Payments | Amount |
|---|---|---|
| Insmed, Inc. INSM | 7 | $6,799 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $3,167 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.